Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
Farmers, ag groups and Extension personnel are sorting through the impacts of the Environmental Protection Agency’s final ...
The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback